Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00667342 · OUTCOME

Mean Duration of Neuropathic Pain Medication

A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma · Source last updated 2023-08-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
Weeks
Interval / dispersion
Standard Deviation
Time frame
From surgery until resolution of NP symptoms, up to 6 months

What was measured

Thirty participants who underwent surgery (31 surgeries) were determined to have neuropathic pain. Four participants received only opioids for NP and 26 participants (for 27 surgeries) were treated with NP specific medications including gabapentin, tricyclic antidepressant, methadone. One participant had 2 different surgical procedures and was analyzed both in the limb sparing group and in the amputation group.

Groups in this outcome

Amputation Group

Participants had metastatic disease at diagnosis.

Limb Sparing Group

Participants had localized disease at diagnosis. One participant had 2 surgeries.

Entire Study Group

Participants enrolled on the study who met the criteria for evaluation of neuropathic pain.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Amputation Group10
Limb Sparing Group16
Entire Study Group26

Analysis denominator · Number of Surgeries

GroupSource count
Amputation Group10
Limb Sparing Group17
Entire Study Group27

Reported measurements

Source class 1
Values in Weeks · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Amputation Group9.08.0Not reportedNot reportedNot reported
Limb Sparing Group9.88.4Not reportedNot reportedNot reported
Entire Study Group9.58.1Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        8.0
        value
        9.0
      2. group Id
        OG001
        spread
        8.4
        value
        9.8
      3. group Id
        OG002
        spread
        8.1
        value
        9.5
denom Units Selected
Number of Surgeries
denoms
  1. counts
    1. group Id
      OG000
      value
      10
    2. group Id
      OG001
      value
      16
    3. group Id
      OG002
      value
      26
    units
    Participants
  2. counts
    1. group Id
      OG000
      value
      10
    2. group Id
      OG001
      value
      17
    3. group Id
      OG002
      value
      27
    units
    Number of Surgeries
description
Thirty participants who underwent surgery (31 surgeries) were determined to have neuropathic pain. Four participants received only opioids for NP and 26 participants (for 27 surgeries) were treated with NP specific medications including gabapentin, tricyclic antidepressant, methadone. One participant had 2 different surgical procedures and was analyzed both in the limb sparing group and in the amputation group.
dispersion Type
Standard Deviation
groups
  1. description
    Participants had metastatic disease at diagnosis.
    id
    OG000
    title
    Amputation Group
  2. description
    Participants had localized disease at diagnosis. One participant had 2 surgeries.
    id
    OG001
    title
    Limb Sparing Group
  3. description
    Participants enrolled on the study who met the criteria for evaluation of neuropathic pain.
    id
    OG002
    title
    Entire Study Group
param Type
MEAN
reporting Status
POSTED
time Frame
From surgery until resolution of NP symptoms, up to 6 months
title
Mean Duration of Neuropathic Pain Medication
type
OTHER_PRE_SPECIFIED
type Units Analyzed
Number of Surgeries
unit Of Measure
Weeks

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice